Presight Capital was founded by Christian Angermayer and Fabian Hansen in 2019. Over the last three years, we have invested into 70+ startups, partnering with founders to build category-defining companies.
We love to partner with other entrepreneurial investors and have a collaborative approach to investing. With our sister fund Presight Partners, we invest in emerging venture capital funds, and are building a strong ecosystem of likeminded partners.
Founder and General Partner of Presight Capital
Founder of Apeiron Investment Group.
Christian Angermayer is an entrepreneur and investor and the founder of Apeiron Investment Group, his private investment firm, and Presight Capital, the flagship venture capital fund for Apeiron. Collectively, Christian has experienced investing and managing companies in the Financial Services (especially fintech and crypto assets), Technology, Life Sciences, Media & Entertainment and Real Estate & Prop-Tech sectors.
In 2000, Christian co-founded Ribopharma (original patents for RNAi technology) which merged with stock market listed US SPAC Alnylam in 2003 and has a $13bn market cap today. Since then, Christian has created, co-founded and invested in numerous successful companies, has raised over $2bn for his portfolio companies, and has been involved in more than 50 successful IPO- and M&A-transactions either as an entrepreneur, investor or advisor.
Today, Christian is one of the most active and significant investors in European fintech companies with a special focus on crypto-currencies and blockchain-related business models through his investment subsidiary Cryptology Asset Group PLC.
In addition to his entrepreneurial activities, Christian places great value on social, political and societal commitments. He is a Young Global Leader of the World Economic Forum, a member of the Presidential Advisory Council of His Excellency President Paul Kagame of Rwanda and a member of the Milken Institute Young Leaders Circle. Christian is a board member of Vienna-based Hayek Institute, a Libertarian and free-markets-focused think-tank and a member of The Court of the London School of Hygiene and Tropical Medicine.
Founder and general partner
Fabian Hansen is the Founder and Managing Director of Presight Capital. A graduate of The London School of Economics (LSE), Fabian has been working in venture capital since 2013.
Over the years, Fabian was an early investor in numerous category-defining companies including AbCellera, Razor Group, Velocity, Syfe, Peptilogics, ATAI Life Sciences, Compass Pathways, Angiex, Sensei Biotherapeutics, Rational Vaccines, and ChemomAb. Fabian serves on the board of Peptilogics, Alloy Therapeutics, Valoreo and Angiex.
Born and raised in Germany, Fabian is fluent in German, English, and Italian. In 2020, he was featured in Forbes’ “30 under 30” list in the Finance category.